Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Other financing activities (2019 - 2025)

Updated

Grace Therapeutics (GRCE) recorded Other financing activities of $1,000 in fiscal Q2 2021 (quarter ended Sep 30, 2020), down 97.2% from $36,000 a year earlier.

Analysis

Grace Therapeutics (GRCE) Other financing activities (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Grace Therapeutics 34.02 Mn -32.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -327,000.00
Mar 31, 2025 -967,000.00
Sep 30, 2020 -1,000.00
Jun 30, 2020 -140,000.00
Mar 31, 2020 74,000.00
Dec 31, 2019 -31,000.00
Sep 30, 2019 -36,000.00
API Access

Grace Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=GRCE&period=max&api_key=YOUR_API_KEY